Negative symptoms of schizophrenia have a negative impact on psychosocial functioning and disease outcome. It is therefore important to investigate the pathophysiology underlying negative symptoms as this may aid the development of better treatment. In the current article, examples from studies investigating neural correlates of negative symptoms in schizophrenia are given. Investigations using both structural and functional magnetic resonance imaging are presented at different levels of symptomatology descriptions, from the more heterogenous construct of negative symptoms to more single discrete symptoms. Some methods to improve imaging studies of negative symptoms in schizophrenia are also suggested.
KirkpatrickBFentonWSCarpenterWTJrMarderSR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32:214-219. doi:10.1093/schbul/sbj053.
2.
KoutsoulerisNGaserCJägerMet al. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. Neuroimage. 2008;39:1600-1612. doi:10.1016/j.neuroimage.2007.10.029.
3.
NenadicISauerHGaserC. Distinct pattern of brain structural deficits in subsyndromes of schizophrenia delineated by psychopathology. Neuroimage. 2010;49:1153-1160. doi:10.1016/j.neuroimage.2009.10.014.
4.
BergeDCarmonaSRoviraMBulbenaASalgadoPVilarroyaO. Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects. Acta Psychiatr Scand. 2011;123:431-439. doi:10.1111/j.1600-0447.2010.01635.x.
5.
VenkatasubramanianGJayakumarPNGangadharBNKeshavanMS. Automated MRI parcellation study of regional volume and thickness of prefrontal cortex (PFC) in antipsychotic-naïve schizophrenia. Acta Psychiatr Scand. 2008;117:420-431. doi:10.1111/j.1600-0447.2008.01198.x.
6.
XiaoYLuiSDengWet al. Altered cortical thickness related to clinical severity but not the untreated disease duration in schizophrenia. Schizophr Bull. 2015;41:201-210. doi:10.1093/schbul/sbt177.
7.
NesvagRSaetrePLawyerGJönssonEGAgartzI. The relationship between symptom severity and regional cortical and grey matter volumes in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:482-490. doi:10.1016/j.pnpbp.2009.01.013.
8.
WaltonEHibarDPvan ErpTGMet al; Karolinska Schizophrenia Project consortium (KaSP). Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium [published online May26, 2017]. Psychol Med. doi:10.1017/S0033291717001283.
9.
RaduaJSchmidtABorgwardtSet al. Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis. JAMA Psychiatry. 2015;72:1243-1251. doi:10.1001/jamapsychiatry.2015.2196.
10.
JuckelGSchlagenhaufFKoslowskiMet al. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage. 2006;29:409-416. doi:10.1016/j.neuroimage.2005.07.051.
11.
NielsenMORostrupEWulffSet al. Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Arch Gen Psychiatry. 2012;69:1195-1204. doi:10.1001/archgenpsychiatry.2012.847.
12.
RecklessGEAndreassenOAServerAØstefjellsTJensenJ. Negative symptoms in schizophrenia are associated with aberrant striato-cortical connectivity in a rewarded perceptual decision-making task. Neuroimage Clin. 2015;8:290-297. doi:10.1016/j.nicl.2015.04.025.
13.
CarpenterWTJrHeinrichsDWWagmanAM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145:578-583. doi:10.1176/ajp.145.5.578.
14.
KirkpatrickBBuchananRWMcKenneyPDAlphsLDCarpenterWTJr.The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989;30:119-123.
15.
BuchananRW. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull. 2007;33:1013-1022. doi:10.1093/schbul/sbl057.
16.
MucciAMerlottiEÜcokAAlemanAGalderisiS. Primary and persistent negative symptoms: concepts, assessments, and neurobiological bases. Schizophr Res. 2017;186:19-28. doi:10.1016/j.schres.2016.05.014.
17.
GalderisiSQuarantelliMVolpeUet al. Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia. Schizophr Bull. 2008;34:393-401. doi:10.1093/schbul/sbm097.
18.
FischerBAKellerWRArangoCet al. Cortical structural abnormalities in deficit versus nondeficit schizophrenia. Schizophr Res. 2012;136:51-54. doi:10.1016/j.schres.2012.01.030.
19.
De RossiPDacquinoCPirasFCaltagironeCSpallettaG. Left nucleus accumbens atrophy in deficit schizophrenia: a preliminary study. Psychiatry Res. 2016;254:48-55. doi:10.1016/j.pscychresns.2016.06.004.
20.
CascellaNGFieldstoneSCRaoVAPearlsonGDSawaASchretlenDJ. Gray-matter abnormalities in deficit schizophrenia. Schizophr Res. 2010;120:63-70. doi:10.1016/j.schres.2010.03.039.
21.
LeiWDengWLiMet al. Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia. Psychiatry Res. 2015;234:219-226. doi:10.1016/j.pscychresns.2015.09.015.
22.
BodnarMHovingtonCLBuchyLMallaAKJooberRLepageM. Cortical thinning in temporo-parietal junction (TPJ) in non-affective first-episode of psychosis patients with persistent negative symptoms. PLoS One. 2014;9:e101372. doi:10.1371/journal.pone.0101372.
23.
VoineskosANFoussiasGLerchJet al. Neuroimaging evidence for the deficit subtype of schizophrenia. JAMA Psychiatry. 2013;70:472-480. doi:10.1001/jamapsychiatry.2013.786.
24.
KitisOOzalayOZenginEBet al. Reduced left uncinate fasciculus fractional anisotropy in deficit schizophrenia but not in non-deficit schizophrenia. Psychiatry Clin Neurosci. 2012;66:34-43. doi:10.1111/j.1440-1819.2011.02293.x.
25.
RowlandLMSpiekerEAFrancisABarkerPBCarpenterWTBuchananRW. White matter alterations in deficit schizophrenia. Neuropsychopharmacology. 2009;34:1514-1522. doi:10.1038/npp.2008.207.
26.
LeiWLiNDengWet al. White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study. Sci Rep. 2015;5:12994. doi:10.1038/srep12994.
27.
SzeszkoPRRobinsonDGAshtariMet al. Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology. 2008;33:976-984. doi:10.1038/sj.npp.1301480.
28.
TakahashiTTakayanagiYNishikawaYet al. Brain neurodevelopmental markers related to the deficit subtype of schizophrenia. Psychiatry Res. 2017;266:10-18. doi:10.1016/j.pscychresns.2017.05.007.
29.
MucciADimaDSoricelliAet al. Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback. Psychol Med. 2015;45:1765-1778. doi:10.1017/S0033291714002943.
30.
KaiserSLyneJAgartzIClarkeMMørch-JohnsenLFaerdenA. Individual negative symptoms and domains—relevance for assessment, pathomechanisms, and treatment. Schizophr Res. 2017;186:39-45. doi:10.1016/j.schres.2016.07.013.
31.
BlanchardJJCohenAS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull. 2006;32:238-245. doi:10.1093/schbul/sbj013.
32.
MarderSRGalderisiS. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16:14-24. doi:10.1002/wps.20385.
33.
StraussGPWaltzJAGoldJM. A review of reward processing and motivational impairment in schizophrenia. Schizophr Bull. 2014;40(suppl 2): S107-S116. doi:10.1093/schbul/sbt197.
34.
KringAMBarchDM. The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol. 2014;24:725-736. doi:10.1016/j.euroneuro.2013.06.007.
35.
KosCvan TolMJMarsmanJBKnegteringHAlemanA. Neural correlates of apathy in patients with neurodegenerative disorders, acquired brain injury, and psychiatric disorders. Neurosci Biobehav Rev. 2016;69:381-401. doi:10.1016/j.neubiorev.2016.08.012.
36.
RothRMFlashmanLASaykinAJMcAllisterTWVidaverR. Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits. Am J Psychiatry. 2004;161:157-159.
37.
Mørch-JohnsenLNesvågRFaerdenAet al. Brain structure abnormalities in first-episode psychosis patients with persistent apathy. Schizophr Res. 2015;164:59-64. doi:10.1016/j.schres.2015.03.001.
38.
TakayanagiYGernerGTakayanagiMet al. Hippocampal volume reduction correlates with apathy in traumatic brain injury, but not schizophrenia. J Neuropsychiatry Clin Neurosci. 2013;25:292-301. doi:10.1176/appi.neuropsych.12040093.
39.
ZipparoLWhitfordTJRedoblado HodgeMAet al. Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:531-538. doi:10.1016/j.pnpbp.2007.10.011.
40.
OhtaniTBouixSHosokawaTet al. Abnormalities in white matter connections between orbitofrontal cortex and anterior cingulate cortex and their associations with negative symptoms in schizophrenia: a DTI study. Schizophr Res. 2014;157:190-197. doi:10.1016/j.schres.2014.05.016.
41.
HovingtonCLBodnarMChakravartyMMJooberRMallaAKLepageM. Investigation of white matter abnormalities in first episode psychosis patients with persistent negative symptoms. Psychiatry Res. 2015;233:402-408. doi:10.1016/j.pscychresns.2015.06.017.
42.
ChuangJYMurrayGKMetastasioAet al. Brain structural signatures of negative symptoms in depression and schizophrenia. Front Psychiatry. 2014;5:116. doi:10.3389/fpsyt.2014.00116.
43.
AsamiTHyuk LeeSBouixSet al. Cerebral white matter abnormalities and their associations with negative but not positive symptoms of schizophrenia. Psychiatry Res. 2014;222:52-59. doi:10.1016/j.pscychresns.2014.02.007.
44.
WaltzJAKasanovaZRossTJet al. The roles of reward, default, and executive control networks in set-shifting impairments in schizophrenia. PLoS One. 2013;8:e57257. doi:10.1371/journal.pone.0057257.
45.
LeeJSChunJWKangJIKangDIParkHJKimJJ. Hippocampus and nucleus accumbens activity during neutral word recognition related to trait physical anhedonia in patients with schizophrenia: an fMRI study. Psychiatry Res. 2012;203:46-53. doi:10.1016/j.pscychresns.2011.09.004.
46.
HarveyPOArmonyJMallaALepageM. Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia. J Psychiatr Res. 2010;44:707-716. doi:10.1016/j.jpsychires.2009.12.008.
47.
RahmCLibergBRecklessGet al. Negative symptoms in schizophrenia show association with amygdala volumes and neural activation during affective processing. Acta Neuropsychiatr. 2015;27:213-220. doi:10.1017/neu.2015.11.
48.
BallmaierMSchlagenhaufFTogaAWet al. Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr Res. 2008;106:140-147. doi:10.1016/j.schres.2008.08.025.
49.
LepageMSergerieKBenoitACzechowskaYDickieEArmonyJL. Emotional face processing and flat affect in schizophrenia: functional and structural neural correlates. Psychol Med. 2011;41:1833-1844. doi:10.1017/S0033291711000031.
50.
GurRELougheadJKohlerCGet al. Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. Arch Gen Psychiatry. 2007;64:1356-1366. doi:10.1001/archpsyc.64.12.1356.
51.
LindnerCDannlowskiUBauerJet al. Affective flattening in patients with schizophrenia: differential association with amygdala response to threat-related facial expression under automatic and controlled processing conditions. Psychiatry Investig. 2016;13:102-111. doi:10.4306/pi.2016.13.1.102.
